临床外科杂志 ›› 2025, Vol. 33 ›› Issue (6): 637-640.doi: 10.3969/j.issn.1005-6483.20240349

• 论著 • 上一篇    下一篇

药物涂层球囊对下肢动脉硬化闭塞症经皮腔内血管成形术后支架内再狭窄病人靶病变血管通畅率、凝血功能及血管内皮功能的影响

刘盛智 龚光 范颖 熊义祥 文倩   

  1. 644000 四川宜宾,宜宾市第二人民医院血管外科(刘盛智、龚光、范颖、熊义祥);西北妇女儿童医院介入医学科(文倩)
  • 收稿日期:2024-03-15 出版日期:2025-06-20 发布日期:2025-06-20
  • 通讯作者: 文倩,Email:Wenqianxx@163.com

The influence of drug-coated balloon catheters on the patency rate of target lesion vessels, coagulation function and vascular endothelial function in patients with restenosis of stents after percutaneous transluminal angioplasty for lower extremity arteriosclerotic occlusion

LIU Shengzhi,GONG Guang,FAN Ying,XIONG Yixiang,WEN Qian   

  1. Department of Vascular surgery,Yibin Second People’s Hospital,Sichuan,Yibin 644000,China
  • Received:2024-03-15 Online:2025-06-20 Published:2025-06-20

摘要: 目的 探讨药物涂层球囊(DCB)对下肢动脉硬化闭塞症(ASO)经皮腔内血管成形术(PTA)后支架内再狭窄(ISR)病人靶病变血管通畅率、凝血功能及血管内皮功能的影响。方法 2020年3月~2022年3月收治的下肢ASO PTA后ISR病人62例,根据其治疗方案分为DCB组(38例)和普通球囊(SAB)组(24例)。两组病人均完成12个月术后随访,观察病人术后靶病变血管一期通畅率、临床驱动血运重建(CD-TLR)率、晚期管腔丢失值(LLL)、踝肱指数(ABI)、凝血功能[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)、 D-二聚体(D-D)]及血管内皮功能[血清内皮素(ET-1)、一氧化氮(NO)、血流介导的血管舒张功能检测(FMD)值]变化,记录两组术后并发症发生情况。结果 DCB组术后12个月靶病变血管一期通畅率(86.84%)高于SAB组(50.00%),CD-TLR率(13.16%)低于SAB组(50.00%), LLL、ABI[(1.39±0.52)mm、(0.76±0.12)]低于SAB组[(1.79±0.64)mm、(0.62±0.11)],两组比较差异有统计学意义(P<0.05);两组间术后不同时间点(24小时,2周)PT、APTT、FIB、D-D水平比较差异无统计学意义(P>0.05)。DCB组术后不同时间点(24小时,2周)血清ET-1水平[(66.65±7.12)pg/ml、(65.58±6.98)pg/ml]均低于SAB组[(71.74±6.92)pg/ml、(68.84±6.51)pg/ml],NO水平[(32.21±4.17)pg/ml、(34.62±3.32)pg/ml]高于SAB组[(28.53±5.23)pg/ml、(31.21±4.19)pg/ml],两组比较差异有统计学意义(P<0.05)。DCB组术后2周FMD值[(12.49±5.33)%]高于SAB组[(9.14±4.42)%],两组比较差异有统计学意义(P<0.05)。两组总并发症发生率分别为21.50% 和 12.50%,两组比较差异无统计学意义(P>0.05)。结论 较SAB相比,DCB可有效保护血管内皮功能,提高下肢ASO病人PTA后ISR的靶病变血管一期通畅率。

关键词: 药物涂层球囊; 下肢动脉硬化闭塞症; 经皮腔内血管成形术; 支架内再狭窄; 靶病变血管; 凝血功能; 血管内皮功能

Abstract: Objective To explore the effects of drug-coated balloons (DCB) on the patency rate of target lesion vessels, coagulation function and vascular endothelial function in patients with in-stent restenosis (ISR) after percutaneous endovascular angioplasty (PTA) for lower extremity arteriosclerosis obliterans (ASO).Methods A total of 62 patients with ISR and ASO admitted to the hospital were retrospectively enrolled between March 2020 and March 2022.According to different treatment methods,they were divided into DCB group (n=38) and common balloon (SAB) group (n=24).All were followed up for 12 months after surgery.The changes in primary patency rate of target lesion vessel,clinically driven-target lesion revascularization (CD-TLR) rate,late loss of values in the lumen (LLL),ankle-brachial index (ABI),coagulation function indexes [prothrombin time (PT),activated partial thromboplastin time (APTT),fibrinogen (FIB),D-dimer (D-D)] and vascular endothelial function indexes [serum endothelin-1 (ET-1),nitric oxide (NO),flow-mediated dilatation (FMD)] were observed,and the occurrence of postoperative complications in the two groups was recorded.Results At 12 months after surgery,primary patency rate of target lesion vessels in DCB group was higher than that in SAB group (86.84% vs 50.00%),CD-TLR rate,LLL and ABI were lower than those in SAB group[13.16%,(1.39±0.52)mm,(0.76±0.12) vs 50.00%,(1.79±0.64) mm,(0.62±0.11);P<0.05].At 24h and 2 weeks after surgery,there was no significant difference in PT,APTT,FIB or D-D between the two groups (P>0.05).At 24h and 2 weeks after surgery,levels of serum ET-1 in DCB group were lower than those in SAB group [(66.65±7.12)pg/ml,(65.58±6.98)pg/ml vs (71.74±6.92)pg/ml,(68.84±6.51)pg/ml)],while NO levels were higher than those in SAB group [(32.21±4.17)pg/ml,(34.62±3.32)pg/ml vs (28.53±5.23)pg/ml,(31.21±4.19)pg/ml;P<0.05].At 2 weeks after surgery,FMD in DCB group was higher than that in SAB group [(12.49±5.33)% vs (9.14±4.42)%,P<0.05].There was no significant difference in the total incidence of complications between the two groups (21.50% vs 12.50%,P>0.05).Conclusion Compared with SAB,DCB can effectively protect vascular endothelial function and improve the primary patency rate of ISR after PTA in patients with lower extremity ASO.

Key words: drug-coated balloon;lower extremity arteriosclerosis obliterans;percutaneous transluminal angioplasty;in-stent restenosis;target lesion vessel;coagulation function;vascular endothelial function

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 邱江. 心脏死亡捐献供肾移植免疫抑制方案的选择[J]. 临床外科杂志, 2016, 24(10): 735 .
[3] 陈忠;王耀东;田毅峰;等. 肝胆管结石病规范化治疗的临床分析[J]. 临床外科杂志, 2016, 24(10): 753 .
[4] 戴强;徐康;周治军;等. 湖北天门地区泌尿系结石成分及特征分析[J]. 临床外科杂志, 2016, 24(10): 789 .
[5] 胡光俊;宋晓阳;陶军. 右美托咪定添加到罗哌卡因中对腰丛坐骨神经阻滞及镇静的影响[J]. 临床外科杂志, 2016, 24(10): 796 .
[6] 胡均贤 徐春林 吴雅兰 . 高血压脑出血微创穿刺清除术后手术相关并发症及预后分析 [J]. 临床外科杂志, 2016, 24(4): 318 .
[7] 龚杰;黄雄;何山等 . 小肠脂肪瘤致肠套叠一例 [J]. 临床外科杂志, 2016, 24(6): 480 .
[8] 侯丁丁 康骅. 近红外荧光在乳腺癌前哨淋巴结活检中的应用现状[J]. 临床外科杂志, 2016, 24(9): 719 .
[9] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[10] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .